Feng Zhang (張鋒), a 2016 Tang Prize winner, explained his latest genome editing tool, called CRISPR/Cas13, in a meeting Wednesday with Tang Prize Foundation CEO Chern Jenn-chuan (陳振川) and a Nobel Prize laureate in Physiology or Medicine at the Massachusetts Institute of Technology (MIT).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Northern Taiwan's new Sanying MRT Line set to open in March 2026
06/25/2025 09:19 PM - Business
Model B EV certified, to launch in Q4: Foxtron
06/25/2025 08:58 PM - Business
TSMC's financial unit to raise capital for forex hedging cost cut
06/25/2025 08:36 PM - Society
CWA issues heat alerts for Thursday, warns of afternoon thunderstorms
06/25/2025 08:10 PM - Society
Taipei Zoo extends Saturday hours from July 5 to Aug. 23
06/25/2025 07:59 PM